Literature DB >> 10077043

Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths.

S T Fan1, C M Lo, C L Liu, C M Lam, W K Yuen, C Yeung, J Wong.   

Abstract

OBJECTIVE: The authors report on the surgical techniques and protocol for perioperative care that have yielded a zero hospital mortality rate in 110 consecutive patients undergoing hepatectomy for hepatocellular carcinoma (HCC). The hepatectomy results are analyzed with the aim of further reducing the postoperative morbidity rate. SUMMARY BACKGROUND DATA: In recent years, hepatectomy has been performed with a mortality rate of <10% in patients with HCC, but a zero hospital mortality rate in a large patient series has never been reported. At Queen Mary Hospital, Hong Kong, the surgical techniques and perioperative management in hepatectomy for HCC have evolved yearly into a final standardized protocol that reduced the hospital mortality rate from 28% in 1989 to 0% in 1996 and 1997.
METHODS: Surgical techniques were designed to reduce intraoperative blood loss, blood transfusion, and ischemic injury to the liver remnant in hepatectomy. Postoperative care was focused on preservation and promotion of liver function by providing adequate tissue oxygenation and immediate postoperative nutritional support that consisted of branched-chain amino acid-enriched solution, low-dose dextrose, medium-chain triglycerides, and phosphate. The pre-, intra-, and postoperative data were collected prospectively and analyzed each year to assess the influence of the evolving surgical techniques and perioperative care on outcome.
RESULTS: Of 330 patients undergoing hepatectomy for HCC, underlying cirrhosis and chronic hepatitis were present in 161 (49%) and 108 (33%) patients, respectively. There were no significant changes in the patient characteristics throughout the 9-year period, but there were significant reductions in intraoperative blood loss and blood transfusion requirements. From 1994 to 1997, the median blood transfusion requirement was 0 ml, and 64% of the patients did not require a blood transfusion. The postoperative morbidity rate remained the same throughout the study period. Complications in the patients operated on during 1996 and 1997 were primarily wound infections; the potentially fatal complications seen in the early years, such as subphrenic sepsis, biliary leakage, and hepatic coma, were absent. By univariate analysis, the volume of blood loss, volume of blood transfusions, and operation time were correlated positively with postoperative morbidity rates in 1996 and 1997. Stepwise logistic regression analysis revealed that the operation time was the only parameter that correlated significantly with the postoperative morbidity rate.
CONCLUSION: With appropriate surgical techniques and perioperative management to preserve function of the liver remnant, hepatectomy for HCC can be performed without hospital deaths. To improve surgical outcome further, strategies to reduce the operation time are being investigated.

Entities:  

Mesh:

Year:  1999        PMID: 10077043      PMCID: PMC1191696          DOI: 10.1097/00000658-199903000-00004

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  40 in total

1.  Postprandial responses of liver blood flow prior to and following hepatectomy in conscious dogs.

Authors:  N Kameoka; Y Nimura; T Sato; M Kato; A Yasui; S Kondo
Journal:  J Surg Res       Date:  1996-03       Impact factor: 2.192

2.  Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy.

Authors:  H Lau; K Man; S T Fan; W C Yu; C M Lo; J Wong
Journal:  Br J Surg       Date:  1997-09       Impact factor: 6.939

3.  Transection of the oesophagus for bleeding oesophageal varices.

Authors:  R N Pugh; I M Murray-Lyon; J L Dawson; M C Pietroni; R Williams
Journal:  Br J Surg       Date:  1973-08       Impact factor: 6.939

4.  High preoperative serum alanine transferase levels: effect on the risk of liver resection in Child grade A cirrhotic patients.

Authors:  R Noun; P Jagot; O Farges; A Sauvanet; J Belghiti
Journal:  World J Surg       Date:  1997-05       Impact factor: 3.352

5.  Prospective evaluation of vacuum pleural drainage after thoracotomy in patients with esophageal carcinoma.

Authors:  H Lau; S Law; J Wong
Journal:  Arch Surg       Date:  1997-07

6.  Conservative hepatic resection for hepatocellular carcinoma of cirrhotic patients.

Authors:  P C Sheen; K T Lee; H Y Chen; J S Chen; C G Ker
Journal:  Int Surg       Date:  1996 Jul-Sep

7.  Anterior approach for difficult major right hepatectomy.

Authors:  E C Lai; S T Fan; C M Lo; K M Chu; C L Liu
Journal:  World J Surg       Date:  1996 Mar-Apr       Impact factor: 3.352

8.  Transthoracic transdiaphragmatic approach for hepatectomy of Couinaud's segments VII and VIII.

Authors:  S Ko; Y Nakajima; H Kanehiro; Y Aomatsu; A Yoshimura; J Taki; T Kin; K Yagura; K Ohashi; H Nakano
Journal:  World J Surg       Date:  1997-01       Impact factor: 3.352

9.  Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors.

Authors:  K Kubota; M Makuuchi; K Kusaka; T Kobayashi; K Miki; K Hasegawa; Y Harihara; T Takayama
Journal:  Hepatology       Date:  1997-11       Impact factor: 17.425

10.  Anatomical hepatectomy for resection or transplantation.

Authors:  J C Emond; R Polastri
Journal:  Am J Surg       Date:  1996-07       Impact factor: 2.565

View more
  226 in total

1.  Comparative study of perioperative management of hepatic resection.

Authors:  K Akashi; S Mizuno; S Isaji
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

Review 2.  Liver resection for cancer.

Authors:  R W Parks; O J Garden
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

3.  Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified?

Authors:  Ronnie Tung Ping Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; Chi Ming Lam; Wai Kei Yuen; Chun Yeung; John Wong
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

4.  A prognostic model and treatment strategy for intrahepatic recurrence of hepatocellular carcinoma after curative resection.

Authors:  Yuzo Umeda; Hiroaki Matsuda; Hiroshi Sadamori; Hiroyoshi Matsukawa; Takahito Yagi; Toshiyoshi Fujiwara
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

5.  Two-stage hepatectomy: tape it and hang it, while you can.

Authors:  Olivier Scatton; Georgios Katsanos; Olivier Soubrane
Journal:  World J Surg       Date:  2012-07       Impact factor: 3.352

6.  Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.

Authors:  Masami Minagawa; Masatoshi Makuuchi; Tadatoshi Takayama; Norihiro Kokudo
Journal:  Ann Surg       Date:  2003-11       Impact factor: 12.969

Review 7.  Protection of the liver during hepatic surgery.

Authors:  Pierre-Alain Clavien; Jean Emond; Jean Nicolas Vauthey; Jacques Belghiti; Ravi S Chari; Steven M Strasberg
Journal:  J Gastrointest Surg       Date:  2004 Mar-Apr       Impact factor: 3.452

8.  Preventive effects of jiedu granules combined with cinobufacini injection versus transcatheter arterial chemoembolization in post-surgical patients with hepatocellular carcinoma: a case-control trial.

Authors:  Zhe Chen; Hong-yun Chen; Qing-bo Lang; Bai Li; Xiao-feng Zhai; Yu-yu Guo; Xiao-qiang Yue; Chang-quan Ling
Journal:  Chin J Integr Med       Date:  2012-05-02       Impact factor: 1.978

9.  Computed tomography (CT)-guided versus laparoscopic radiofrequency ablation: a single-institution comparison of morbidity rates and hospital costs.

Authors:  Maria A Cassera; Kevin W Potter; Michael B Ujiki; Lee L Swanström; Paul D Hansen
Journal:  Surg Endosc       Date:  2010-09-17       Impact factor: 4.584

10.  Resection or transplant-listing for solitary hepatitis C-associated hepatocellular carcinoma: an intention-to-treat analysis.

Authors:  Hiroshi Sogawa; Brian Shrager; Ghalib Jibara; Parissa Tabrizian; Sasan Roayaie; Myron Schwartz
Journal:  HPB (Oxford)       Date:  2012-08-30       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.